
Keywords: تست الیزا; Regulatory framework; Quality evaluation system; National reference panel; HIV diagnostics; China; HIV; Human immunodeficiency virus; AIDS; Acquired Immuno-Deficiency Syndrome; NAT; nucleic acid tests; ELISA; enzyme-linked immunosorbent assay; NIFDC; Nati